Effect of triphala on a murine model of isoniazid and rifampicin induced model of hepatotoxicity

D. S. Sushma, Preethi J. Shenoy, M. S. Rukmini, Nischal Salian, Seema Rai, Vinaykumar Sayeli, Sohil Takodara

Research output: Contribution to journalArticle

Abstract

The aim of the study was to evaluate the effect of triphala on murine model of isoniazid and rifampicin induced hepatotoxicity. Thirty wistar rats of either sex, weighing 150-250 g were randomly divided into five groups of six animals each - Normal control, hepatotoxic control, Triphala 250mg group, Triphala 500mg group and standard control. Hepatotoxicity was induced in all groups except normal control, by administering isoniazid 100mg/kg body weight intraperitoneally and rifampicin 100mg/kg body weight orally, for 21 days. Triphala 250mg, Triphala 500mg and standard control groups were treated simultaneously with Triphala at doses 250mg/kg/500 mg/kg and Silymarin2.5mg/kg respectively for 21 days. The blood samples were collected by cardiac puncture under ether anesthesia, for biochemical estimation of liver enzymes, total proteins, albumin, total and direct bilirubin. Subsequently, the rats were sacrificed and the liver was dissected for histopathological evaluation. The hepatotoxic group showed significant increase in liver enzymes(P < 0.001) and total and direct bilirubin (p < 0.001, p=0.006 respectively), compared to normal control. Triphala 250mg, Triphala 500mg and Silymarin groups showed statistically significant decrease in liver enzymes and total bilirubin and direct bilirubin compared to hepatotoxic control (p < 0.001).There was no statistically significant difference in the total protein and albumin among groups. Histopathological evaluation of liver further conferred the hepatotprotective potential of Triphala. To conclude, Triphala at doses of 250mg/kg and 500mg/kg showed hepatoprotective effect in murine model of isoniazid and rifampicin induced hepatotoxicity.

Original languageEnglish
Pages (from-to)618-624
Number of pages7
JournalResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Volume7
Issue number1
Publication statusPublished - 01-01-2016

Fingerprint

Isoniazid
Rifampin
Liver
Bilirubin
Rats
Albumins
Enzymes
Body Weight
triphala
Silymarin
Control Groups
Weighing
Punctures
Ether
Wistar Rats
Animals
Proteins
Blood
Anesthesia

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{b19d1bc7b6534efebf47ee589228ba29,
title = "Effect of triphala on a murine model of isoniazid and rifampicin induced model of hepatotoxicity",
abstract = "The aim of the study was to evaluate the effect of triphala on murine model of isoniazid and rifampicin induced hepatotoxicity. Thirty wistar rats of either sex, weighing 150-250 g were randomly divided into five groups of six animals each - Normal control, hepatotoxic control, Triphala 250mg group, Triphala 500mg group and standard control. Hepatotoxicity was induced in all groups except normal control, by administering isoniazid 100mg/kg body weight intraperitoneally and rifampicin 100mg/kg body weight orally, for 21 days. Triphala 250mg, Triphala 500mg and standard control groups were treated simultaneously with Triphala at doses 250mg/kg/500 mg/kg and Silymarin2.5mg/kg respectively for 21 days. The blood samples were collected by cardiac puncture under ether anesthesia, for biochemical estimation of liver enzymes, total proteins, albumin, total and direct bilirubin. Subsequently, the rats were sacrificed and the liver was dissected for histopathological evaluation. The hepatotoxic group showed significant increase in liver enzymes(P < 0.001) and total and direct bilirubin (p < 0.001, p=0.006 respectively), compared to normal control. Triphala 250mg, Triphala 500mg and Silymarin groups showed statistically significant decrease in liver enzymes and total bilirubin and direct bilirubin compared to hepatotoxic control (p < 0.001).There was no statistically significant difference in the total protein and albumin among groups. Histopathological evaluation of liver further conferred the hepatotprotective potential of Triphala. To conclude, Triphala at doses of 250mg/kg and 500mg/kg showed hepatoprotective effect in murine model of isoniazid and rifampicin induced hepatotoxicity.",
author = "Sushma, {D. S.} and Shenoy, {Preethi J.} and Rukmini, {M. S.} and Nischal Salian and Seema Rai and Vinaykumar Sayeli and Sohil Takodara",
year = "2016",
month = "1",
day = "1",
language = "English",
volume = "7",
pages = "618--624",
journal = "Research Journal of Pharmaceutical, Biological and Chemical Sciences",
issn = "0975-8585",
publisher = "RJPBCS",
number = "1",

}

Effect of triphala on a murine model of isoniazid and rifampicin induced model of hepatotoxicity. / Sushma, D. S.; Shenoy, Preethi J.; Rukmini, M. S.; Salian, Nischal; Rai, Seema; Sayeli, Vinaykumar; Takodara, Sohil.

In: Research Journal of Pharmaceutical, Biological and Chemical Sciences, Vol. 7, No. 1, 01.01.2016, p. 618-624.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of triphala on a murine model of isoniazid and rifampicin induced model of hepatotoxicity

AU - Sushma, D. S.

AU - Shenoy, Preethi J.

AU - Rukmini, M. S.

AU - Salian, Nischal

AU - Rai, Seema

AU - Sayeli, Vinaykumar

AU - Takodara, Sohil

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The aim of the study was to evaluate the effect of triphala on murine model of isoniazid and rifampicin induced hepatotoxicity. Thirty wistar rats of either sex, weighing 150-250 g were randomly divided into five groups of six animals each - Normal control, hepatotoxic control, Triphala 250mg group, Triphala 500mg group and standard control. Hepatotoxicity was induced in all groups except normal control, by administering isoniazid 100mg/kg body weight intraperitoneally and rifampicin 100mg/kg body weight orally, for 21 days. Triphala 250mg, Triphala 500mg and standard control groups were treated simultaneously with Triphala at doses 250mg/kg/500 mg/kg and Silymarin2.5mg/kg respectively for 21 days. The blood samples were collected by cardiac puncture under ether anesthesia, for biochemical estimation of liver enzymes, total proteins, albumin, total and direct bilirubin. Subsequently, the rats were sacrificed and the liver was dissected for histopathological evaluation. The hepatotoxic group showed significant increase in liver enzymes(P < 0.001) and total and direct bilirubin (p < 0.001, p=0.006 respectively), compared to normal control. Triphala 250mg, Triphala 500mg and Silymarin groups showed statistically significant decrease in liver enzymes and total bilirubin and direct bilirubin compared to hepatotoxic control (p < 0.001).There was no statistically significant difference in the total protein and albumin among groups. Histopathological evaluation of liver further conferred the hepatotprotective potential of Triphala. To conclude, Triphala at doses of 250mg/kg and 500mg/kg showed hepatoprotective effect in murine model of isoniazid and rifampicin induced hepatotoxicity.

AB - The aim of the study was to evaluate the effect of triphala on murine model of isoniazid and rifampicin induced hepatotoxicity. Thirty wistar rats of either sex, weighing 150-250 g were randomly divided into five groups of six animals each - Normal control, hepatotoxic control, Triphala 250mg group, Triphala 500mg group and standard control. Hepatotoxicity was induced in all groups except normal control, by administering isoniazid 100mg/kg body weight intraperitoneally and rifampicin 100mg/kg body weight orally, for 21 days. Triphala 250mg, Triphala 500mg and standard control groups were treated simultaneously with Triphala at doses 250mg/kg/500 mg/kg and Silymarin2.5mg/kg respectively for 21 days. The blood samples were collected by cardiac puncture under ether anesthesia, for biochemical estimation of liver enzymes, total proteins, albumin, total and direct bilirubin. Subsequently, the rats were sacrificed and the liver was dissected for histopathological evaluation. The hepatotoxic group showed significant increase in liver enzymes(P < 0.001) and total and direct bilirubin (p < 0.001, p=0.006 respectively), compared to normal control. Triphala 250mg, Triphala 500mg and Silymarin groups showed statistically significant decrease in liver enzymes and total bilirubin and direct bilirubin compared to hepatotoxic control (p < 0.001).There was no statistically significant difference in the total protein and albumin among groups. Histopathological evaluation of liver further conferred the hepatotprotective potential of Triphala. To conclude, Triphala at doses of 250mg/kg and 500mg/kg showed hepatoprotective effect in murine model of isoniazid and rifampicin induced hepatotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=84955257354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955257354&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 618

EP - 624

JO - Research Journal of Pharmaceutical, Biological and Chemical Sciences

JF - Research Journal of Pharmaceutical, Biological and Chemical Sciences

SN - 0975-8585

IS - 1

ER -